CLINICAL_TRIALS
trial_result
· 2025-09-09
Clinical Trial Update: Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer [Phase 1]
Summary
Phase 1 trial in patients with human papillomavirus-associated cancers conducted by Toragen, Inc. has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Toragen, Inc. | Conditions: HPV Associated Cancers | Phase 1 | Status: COMPLETED